AnneChristensenDO

PubMed

• 117 citations
  Epac1 and cAMP-dependent Protein Kinase Holoenzyme Have Similar cAMP Affinity, but Their cAMP Domains Have Distinct Structural Features and Cyclic Nucleotide Recognition
  Khanh K. Dao, Knut Teigen, Reidun K. Kopperud, Erlend Hodneland, Frank Schwede, Anne Elisabeth Christensen, Aurora Martinez, Stein Ove Døskeland> ;The Journal of Biological Chemistry. 2006 Jul 28
• 31 citations
  Substrate enhances the sensitivity of type I protein kinase A to cAMP
  Kristin Viste, Reidun K. Kopperud, Anne Elisabeth Christensen, Stein Ove Døskeland> ;The Journal of Biological Chemistry. 2005 Apr 8
• 36 citations
  cAMP protects neutrophils against TNF-α-induced apoptosis by activation of cAMP-dependent protein kinase, independently of exchange protein directly activated by cAMP ...
  Camilla Krakstad, Anne Elisabeth Christensen, Stein Ove Døskeland> ;Journal of Leukocyte Biology. 2004 Sep 1
• 344 citations
  cAMP Analog Mapping of Epac1 and cAMP Kinase DISCRIMINATING ANALOGS DEMONSTRATE THAT Epac AND cAMP KINASE ACT SYNERGISTICALLY TO PROMOTE PC-12 CELL NEURITE EXTENSION
  Anne Elisabeth Christensen, Frode Selheim, Johan de Rooij, Sarah Dremier, Frank Schwede, Khanh K. Dao, Aurora Martinez, Carine Maenhaut, Johannes L. Bos, Hans G. Genie...> ;The Journal of Biological Chemistry. 2003 Sep 12
• 602 citations
  A novel Epac-specific cAMP analogue demonstrates independent regulation of Rap1 and ERK.
  Jorrit M. Enserink, Anne Elisabeth Christensen, Johan de Rooij, Miranda van Triest, Frank Schwede, Hans G. Genieser, Stein Ove Døskeland, Jonathan L. Blank, Johannes L...> ;Nature Cell Biology. 2002 Nov 1
• 53 citations
  Formation of Inactive cAMP-saturated Holoenzyme of cAMP-dependent Protein Kinase under Physiological Conditions
  Reidun K. Kopperud, Anne Elisabeth Christensen, Endre Kjærland, Kristin Viste, Hans Kleivdal, Stein Ove Døskeland> ;The Journal of Biological Chemistry. 2002 Apr 19
• Tumor suppressor p53 protein is a new target for the metastasis-associated Mts1/S100A4 protein: functional consequences of their interaction.
  Grigorian M, Andresen S, Tulchinsky E, Kriajevska M, Carlberg C, Kruse C, Cohn M, Ambartsumian N, Christensen A, Selivanova G, Lukanidin E> ;J. Biol. Chem.. 2001-06-22
• A regulatory hydrophobic area in the flexible joint region of plasminogen activator inhibitor-1, defined with fluorescent activity-neutralizing ligands. Ligand-induced...
  Egelund R, Einholm AP, Pedersen KE, Nielsen RW, Christensen A, Deinum J, Andreasen PA> ;J. Biol. Chem.. 2001-04-20
• Ligand binding properties of the very low density lipoprotein receptor. Absence of the third complement-type repeat encoded by exon 4 is associated with reduced bindin...
  Rettenberger PM, Oka K, Ellgaard L, Petersen HH, Christensen A, Martensen PM, Monard D, Etzerodt M, Chan L, Andreasen PA> ;J. Biol. Chem.. 1999-03-26
• Very low density lipoprotein receptor binds and mediates endocytosis of urokinase-type plasminogen activator-type-1 plasminogen activator inhibitor complex.
  Heegaard CW, Simonsen AC, Oka K, Kjøller L, Christensen A, Madsen B, Ellgaard L, Chan L, Andreasen PA> ;J. Biol. Chem.. 1995-09-01
• Organization of polysomes from pre-existing ribosomes in chick oviduct by a secondary administration of either estradiol or progesterone.
  Palmiter RD, Christensen AK, Schimke RT> ;J. Biol. Chem.. 1970-02-25
• Join now to see all